Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Golgi apparatus membrane protein TVP23 homolog B (TVP23B) is a 205-amino-acid, multipass transmembrane protein, with a predicted molecular mass of ~23 kDa and an isoelectric point of 8.62[3]. It is predicted to localize primarily to the Golgi membrane and cytoplasm, and participates in vesicle-mediated transport and protein secretion, contributing to cellular homeostasis and response to metabolic stress, especially in the context of retinal cells[1][4]. The protein belongs to the FAM18/TVP23 superfamily and contains the DUF846 domain, a feature conserved across diverse eukaryotic species. TVP23B is expressed in nearly all tissues and cell types, without tissue-specific restriction, including heightened expression in bladder and other tissues[3][5]. Current evidence does not indicate TVP23B as a direct therapeutic target (such as a receptor, enzyme, ion channel, or transporter), nor is it recognized as the target of any approved drugs or clear disease biomarkers. However, gene associations with Charcot-Marie-Tooth disease and speculative correlations with diabetic retinopathy suggest potential relevance in disease, warranting further investigation into its roles and possible therapeutic or diagnostic value[1][4]. TVP23B's molecular function aligns with essential intracellular trafficking and protein sorting, underscoring its contribution to core cellular processes rather than direct druggability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Golgi apparatus membrane protein TVP23 homolog B (TVP23B).